Squarepoint’s Gossamer Bio GOSS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-217,921
Closed -$240K 2910
2025
Q1
$240K Buy
217,921
+145,977
+203% +$161K ﹤0.01% 2287
2024
Q4
$65.1K Sell
71,944
-75,013
-51% -$67.9K ﹤0.01% 2612
2024
Q3
$145K Buy
+146,957
New +$145K ﹤0.01% 2264
2024
Q2
Sell
-300,034
Closed -$354K 2671
2024
Q1
$354K Buy
300,034
+253,593
+546% +$299K ﹤0.01% 1841
2023
Q4
$42.4K Buy
+46,441
New +$42.4K ﹤0.01% 2380
2023
Q3
Sell
-150,063
Closed -$180K 2613
2023
Q2
$180K Sell
150,063
-509,862
-77% -$612K ﹤0.01% 2109
2023
Q1
$832K Sell
659,925
-255,001
-28% -$321K ﹤0.01% 1249
2022
Q4
$1.99M Buy
914,926
+674,380
+280% +$1.46M 0.01% 785
2022
Q3
$2.88M Buy
240,546
+207,985
+639% +$2.49M 0.01% 637
2022
Q2
$273K Sell
32,561
-18,186
-36% -$152K ﹤0.01% 1612
2022
Q1
$440K Buy
+50,747
New +$440K ﹤0.01% 1553
2021
Q3
Sell
-10,575
Closed -$86K 2434
2021
Q2
$86K Sell
10,575
-19,613
-65% -$160K ﹤0.01% 2442
2021
Q1
$279K Sell
30,188
-23,929
-44% -$221K ﹤0.01% 1934
2020
Q4
$523K Buy
54,117
+39,831
+279% +$385K ﹤0.01% 1478
2020
Q3
$177K Buy
14,286
+393
+3% +$4.87K ﹤0.01% 1980
2020
Q2
$181K Sell
13,893
-4,430
-24% -$57.7K ﹤0.01% 1776
2020
Q1
$186K Sell
18,323
-15,114
-45% -$153K ﹤0.01% 1489
2019
Q4
$523K Buy
+33,437
New +$523K ﹤0.01% 1708